cysteine has been researched along with diclofenac in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gelboin, HV; Goldfarb, I; Gonzalez, FJ; Krausz, KW; Yang, TJ | 1 |
Jones, JA; Kaphalia, L; Liebler, DC; Treinen-Moslen, M | 1 |
Díaz, Y; Fuentes, A; Izzo, C; Padrón, L; Rivas, C; Vargas, F; Zoltan, T | 1 |
Chiba, M; Inoue, K; Ishii, Y; Ohe, T; Shibata, Y; Takahashi, H | 1 |
Endo, T; Harada, H; Kobayashi, M; Toyoda, Y | 1 |
Olas, B | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for cysteine and diclofenac
Article | Year |
---|---|
Medical Functions of Hydrogen Sulfide.
Topics: Angiogenesis Inducing Agents; Cardiovascular Agents; Cysteine; Diclofenac; Disulfides; Heart; Humans; Hydrogen Sulfide; Kidney; Levodopa; Prostaglandins F, Synthetic; Reperfusion Injury; Sulfides; Thioctic Acid; Thiones; Vasodilator Agents | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for cysteine and diclofenac
Article | Year |
---|---|
An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys.
Topics: Alleles; Amino Acid Substitution; Antibodies, Monoclonal; Antibody Specificity; Arginine; Aryl Hydrocarbon Hydroxylases; Cysteine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diclofenac; Enzyme-Linked Immunosorbent Assay; Genetic Variation; Humans; Hybridomas; Isoenzymes; Phenanthrenes; Polymorphism, Genetic; Protein Binding; Recombinant Proteins; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tolbutamide | 2000 |
Proteomic characterization of metabolites, protein adducts, and biliary proteins in rats exposed to 1,1-dichloroethylene or diclofenac.
Topics: Animals; Bile; Cysteine; Dichloroethylenes; Diclofenac; Glutathione; Male; Mass Spectrometry; Molecular Structure; Proteins; Proteomics; Rats; Rats, Sprague-Dawley | 2003 |
Photodegradation and in vitro phototoxicity of aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cysteine; Dermatitis, Phototoxic; Diclofenac; Erythrocytes; Glutathione; Hemolysis; Humans; In Vitro Techniques; Linoleic Acid; Lipid Peroxidation; Luminescence; Oxidants; Oxidation-Reduction; Oxygen; Photolysis; Serum Albumin; Ultraviolet Rays | 2007 |
A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide.
Topics: Biotransformation; Carbon Radioisotopes; Chromans; Clozapine; Cyclohexane Monoterpenes; Cysteine; Diclofenac; Humans; Microsomes, Liver; Monoterpenes; Pharmaceutical Preparations; Sodium Cyanide; Sulfur Radioisotopes; Technology, Pharmaceutical; Thiazolidinediones; Troglitazone | 2009 |
Cysteine amide adduct formation from carboxylic acid drugs via UGT-mediated bioactivation in human liver microsomes.
Topics: Amides; Anti-Inflammatory Agents, Non-Steroidal; Carboxylic Acids; Chromatography, High Pressure Liquid; Cysteine; Diclofenac; Glucuronosyltransferase; Humans; Ibuprofen; In Vitro Techniques; Ketoprofen; Microsomes, Liver; Spectrometry, Mass, Electrospray Ionization | 2015 |